On Invalid Date, Caredx (NASDAQ: CDNA) reported Q2 2023 earnings per share (EPS) of -$0.46, up 12.2% year over year. Total Caredx earnings for the quarter were -$24.95 million. In the same quarter last year, Caredx's earnings per share (EPS) was -$0.41.
On Invalid Date, Caredx (NASDAQ: CDNA) reported Q2 2023 revenue of $70.30 million up 12.81% year over year. In the same quarter last year, Caredx's revenue was $80.63 million.
What was CDNA's revenue growth in the past year?
As of Q3 2023, Caredx's revenue has grown -1.76% year over year. This is 3.67 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 1.91%. Caredx's revenue in the past year totalled $309.31 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.